Lower Extremity Peripheral Artery Disease Guideline Hub
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease
Co-Vice Chair: Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM
Co-Vice Chair: Philip P. Goodney, MD, MS, DFSVS
Full Text PDF
2024 Lower Extremity Peripheral Artery Disease Guideline-at-a-Glance
-
See what’s inside:
- Top 10 Take-Home Messages
- Comparison Tables
Overview
The 2024 ACC/AHA/Multisociety PAD Guideline highlights the importance of peripheral artery disease (PAD) as a public health issue that is often overlooked and underserved in many communities and is associated with increased risk of amputation, major cardiovascular events, impaired quality of life, and poor functional status. The recommendations emphasize the importance of assessing for PAD-related risk amplifiers and evidence of health disparities, as well as utilization of effective medical therapies and lifestyle interventions when developing patient-centered treatment plans.
Talk to Patients About Peripheral Artery Disease Health Risks and Disparities
Footnotes
Developed in Collaboration With and Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, American Podiatric Medical Association, Association of Black Cardiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine, Society for Vascular Nursing, Society for Vascular Surgery, Society of Interventional Radiology, and Vascular & Endovascular Surgery Society
This document was approved by the American College of Cardiology Clinical Policy Approval Committee in December 2023, the American Heart Association Science Advisory and Coordinating Committee in January 2024, and the American College of Cardiology Science and Quality Committee and the American Heart Association Executive Committee in February 2024.